VC  OrbiMed Advisors

http://www.orbimed.com





     Office Locations:

601 Lexington Avenue, 54th Floor
New York, NY 10022
Phone: 212-739-6400

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    OrbiMed is the world's largest healthcare-dedicated investment firm manages over $14 billion across public and private company investments worldwide. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds. OrbiMed seeks to be the capital provider of choice for life sciences companies pursuing growth and new opportunities. As a result of OrbiMed's growing capabilities in private equity, the firm launched a dedicated venture capital fund, Caduceus Private Investments, in 2000. Caduceus Private Investments II followed in 2003 and Caduceus Private Investments III was launched in 2006 with committed capital of over $500 million. In 2011 OrbiMed launched a Royalty Opportunities fund, focused on investing in healthcare royalty streams. Today, OrbiMed has a singular focus on seeking successful investments on a worldwide basis across the entire spectrum of private and publicly-traded life sciences companies. For privately-held companies, OrbiMed typically invests between $5 million and $40 million and the firm prefers mid-stage companies focused on drug development, drug discovery, and medical devices. The firm announced in Fall of 2013 the close of OrbiMed Private Investments V, LP, with just over $735 million in commitments, including approximately $36 million from the General Partner. In December 2015, the firm announced OrbiMed Private Investments VI, LP, with $950 million in limited partner commitments.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Carl L. Gordon Ph.D, CFA Founding General Partner
    Daniel Rhee Chief Technology Officer
    Evan Sotiriou Chief Financial Officer
    Geoffrey C. Hsu CFA General Partner
    Jonathan T. Silverstein JD General Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      04/09/2018


      Constellation Pharmaceuticals


      MA


      $100,000,000


      


      04/04/2018


      Arvinas


      CT


      $55,000,000


      Series C


      03/08/2018


      Prevail Therapeutics


      NY


      $75,000,000


      Series A


      01/04/2018


      Neurogastrx


      CA


      $45,000,000


      Series A


      12/14/2017


      Pionyr Immunotherapeutics


      CA


      $62,000,000


      Series B


      12/14/2017


      Kyn Therapeutics


      MA


      $49,000,000


      Series A


      12/04/2017


      Atox Bio


      NC


      $30,000,000


      


      11/30/2017


      resTORbio


      MA


      $40,000,000


      Series B


      11/08/2017


      Tricida


      CA


      $57,500,000


      Series D


      10/24/2017


      NeuroPace


      CA


      $74,000,000


      


      10/17/2017


      Gemini Therapeutics


      MA


      $42,500,000


      Series A


      09/18/2017


      Sonendo


      CA


      $50,000,000


      Growth


      08/31/2017


      ARMO Biosciences


      CA


      $67,000,000


      Series C-1


      07/27/2017


      Cyrus Biotechnology


      WA


      $8,000,000


      Series A


      07/12/2017


      E-Scape Bio


      CA


      $63,000,000


      Series A Extension


      05/23/2017


      TP Therapeutics


      CA


      $45,000,000


      Series C


      04/27/2017


      Avedro


      MA


      $42,000,000


      


      04/26/2017


      Arsanis


      MA


      $45,500,000


      Series D


     

    Portfolio companies include:


      Acceleron Pharma
        web link


      Acutus Medical
        web link


      Adicet Bio


      Adimab
        web link


      Aduro BioTech
        web link


      Aeglea Biotherapeutics
        web link


      Aerpio Therapeutics
        web link


      Afimed
        web link


      Alector
        web link


      Alpine Immune Sciences
        web link


      Amarin
        web link


      Ambit Biosciences
        web link


      Amnis
        web link


      Anthera
        web link


      Aragon Pharmaceuticals
        web link


      ARMO Biosciences
        web link


      Arsanis
        web link


      Arsanis Biosceinces
        web link


      Arvinas
        web link


      Athersys
        web link


      Atox Bio
        web link


      Audentes Therapeutics
        web link


      Augmedix
        web link


      Avedro
        web link


      Avitide
        web link


      Bharat Serums and Vaccines
        web link


      Biodel
        web link


      Biolex
        web link


      Bonovo Orthopedics
        web link


      CardiAQ Valve Technologies
        web link


      Cardioxyl Pharmaceuticals
        web link


      Cerapedics
        web link


      Cerenis Therapeutics
        web link


      Cerimon Pharmaceuticals
        web link


      ChemoCentryx
        web link


      Civitas Therapeutics
        web link


      Cleave Biosciences
        web link


      Complete Genomics
        web link


      Constellation Pharmaceuticals
        web link


      Crown Biosciences
        web link


      Cyrus Biotechnology
        web link


      DFine
        web link


      Dimension Therapeutics
        web link


      E-Scape Bio
        web link


      Ecron Acunova
        web link


      Eddingpharm
        web link


      Enobia
        web link


      ForteBio
        web link


      Gemini Therapeutics
        web link


      Glaukos
        web link


      Good Start Genetics
        web link


      Guardant Health
        web link


      Igenica
        web link


      Inhibitex
        web link


      Inspire Medical
        web link


      Insulet
        web link


      Invitae
        web link


      Iroko Pharmaceuticals
        web link


      Kala Pharmaceuticals
        web link


      Kalidex Pharmaceuticals
        web link


      Kyn Therapeutics
        web link


      Loxo Oncology
        web link


      MacroGenics
        web link


      MethylGene
        web link


      MID Labs
        web link


      Natera
        web link


      NeuroAxon
        web link


      Neurogastrx
        web link


      NeuroPace
        web link


      NextCure


      NxStage Medical
        web link


      OmniGuide
        web link


      ORIC Pharmaceuticals
        web link


      Otonomy
        web link


      Pacira Pharmaceuticals
        web link


      PharmAbcine
        web link


      Pieris AG
        web link


      Pionyr Immunotherapeutics
        web link


      PMV Pharma
        web link


      Practice Fusion
        web link


      Prevail Therapeutics
        web link


      Principia Biopharma
        web link


      Promentis Pharmaceuticals
        web link


      Realton
        web link


      Receptos
        web link


      Relypsa
        web link


      Response BioMedical Corp.
        web link


      resTORbio
        web link


      Rhythm
        web link


      Roka Bioscience
        web link


      SAGE Therapeutics
        web link


      scPharmaceuticals
        web link


      Selecta
        web link


      Selecta Biosciences
        web link


      Shasun
        web link


      Sientra
        web link


      Sikka Software
        web link


      Singulex
        web link


      SMT Research and Development
        web link


      Sonendo
        web link


      SuperDimension
        web link


      Supernus Pharmaceuticals
        web link


      Symbiomix Therapeutics
        web link


      Syndax Pharmaceuticals
        web link


      Synlogic
        web link


      TELA Bio
        web link


      TigerText
        web link


      TP Therapeutics
        web link


      Treato
        web link


      Tricida
        web link


      True North Therapeutics
        web link


      Vessix Vascular
        web link


      Viewray
        web link


      Whale Imaging
        web link


     

    Recent News: